UK markets closed

IRadimed Corporation (IRMD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
40.81-0.09 (-0.22%)
As of 03:13PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 517.97M
Enterprise value 470.25M
Trailing P/E 30.30
Forward P/E 26.74
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.94
Price/book (mrq)7.25
Enterprise value/revenue 7.17
Enterprise value/EBITDA 22.61

Trading information

Stock price history

Beta (5Y monthly) 0.86
52-week change 3-1.61%
S&P500 52-week change 324.19%
52-week high 351.04
52-week low 336.12
50-day moving average 342.68
200-day moving average 343.87

Share statistics

Avg vol (3-month) 358.44k
Avg vol (10-day) 343.03k
Shares outstanding 512.66M
Implied shares outstanding 612.66M
Float 86.54M
% held by insiders 137.10%
% held by institutions 154.98%
Shares short (15 Apr 2024) 4104.88k
Short ratio (15 Apr 2024) 42.35
Short % of float (15 Apr 2024) 41.43%
Short % of shares outstanding (15 Apr 2024) 40.83%
Shares short (prior month 15 Mar 2024) 4112.91k

Dividends & splits

Forward annual dividend rate 40.15
Forward annual dividend yield 40.37%
Trailing annual dividend rate 30.15
Trailing annual dividend yield 30.37%
5-year average dividend yield 4N/A
Payout ratio 411.11%
Dividend date 312 Jan 2024
Ex-dividend date 421 Dec 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 26.22%
Operating margin (ttm)29.57%

Management effectiveness

Return on assets (ttm)14.10%
Return on equity (ttm)23.70%

Income statement

Revenue (ttm)65.56M
Revenue per share (ttm)5.20
Quarterly revenue growth (yoy)17.40%
Gross profit (ttm)N/A
EBITDA 20.8M
Net income avi to common (ttm)17.19M
Diluted EPS (ttm)1.35
Quarterly earnings growth (yoy)23.60%

Balance sheet

Total cash (mrq)49.76M
Total cash per share (mrq)3.93
Total debt (mrq)2.04M
Total debt/equity (mrq)2.86%
Current ratio (mrq)4.66
Book value per share (mrq)5.64

Cash flow statement

Operating cash flow (ttm)13.47M
Levered free cash flow (ttm)8.4M